Short Interest in Hypermarcas (OTCMKTS:HYPMY) Increases By 183.8%

Hypermarcas (OTCMKTS:HYPMY) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 5,807 shares, a growth of 183.8% from the June 30th total of 2,046 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 27,320 shares, the days-to-cover ratio is currently 0.2 days.

Hypermarcas Price Performance

Shares of OTCMKTS HYPMY traded up $0.09 during mid-day trading on Tuesday, hitting $4.15. The company had a trading volume of 31,530 shares, compared to its average volume of 22,990. The business’s 50-day simple moving average is $4.14 and its 200-day simple moving average is $4.38. Hypermarcas has a 12 month low of $3.71 and a 12 month high of $5.50. The firm has a market cap of $2.92 billion, a P/E ratio of 8.65 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last released its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $383.13 million for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. As a group, sell-side analysts predict that Hypermarcas will post 0.53 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HYPMY. Jefferies Financial Group upgraded Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, Hypermarcas currently has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.